Differences Between Patients with Slightly Reduced and Preserved Ejection Fraction at Admission to a Cardiac Rehabilitation Program
Keywords:
heart failure, exercise test, ventricular ejection fraction, oxygen consumption, quality of lifeAbstract
Background: The European Society of Cardiology and the American Heart Association stratify heart failure (HR) according to left ventricular ejection fraction (LVEF), recently the slightly reduced LVEF HR was added (41-49%), with this updated classification the behavior of these patients in clinical variables, oxygen consumption within the context of cardiac rehabilitation is unknown.
Objective: The aim of the present study was to determine the differences between patients with heart failure with slightly reduced and preserved ejection fraction at the beginning of a cardiac rehabilitation program.
Methods: Quantitative cross-sectional study, participants were divided into two groups according to LVEF: heart failure with slightly reduced LVEF (HR-LEF) and heart failure with preserved LVEF (HR-EFp).
Results: 23 participants with FC-FElir and 22 (FC-FEp); 60.9% male; mean age was 64.65 ± (11.02). The diagnosis of diabetes mellitus was 56% in the group (HR-FElir) vs. 22% in the (HR-FEp) group, p = 0.034. According to the risk stratification in cardiac rehabilitation, a lower probability of adverse event was found in patients (HR-FElir) p = 0.000. The average peak VO2 of the stress test was 27.0 ± (8.3) and 28.2 ± (8.9) for (FC-FElir) and (HR-FEp) respectively.
Conclusions: Patients with slightly reduced LVEF have lower oxygen consumption and quality of life compared to patients with preserved LVEF. A higher prevalence of diabetes was also identified in participants with slightly reduced LVEF upon admission to a cardiac rehabilitation program.
Downloads
References
1. Porth CM, Grossman S. Porth fisiopatología alteraciones de salud conceptos básicos. 9ed. New York. Wolters Kluwer; 2014. p.603-14.
2. Kurmani S, Squire I. Acute Heart Failure: Definition, Classification and Epidemiology. Curr Heart Fail Rep. 2017;14(5):385-92. DOI: https://doi.org/10.1007/s11897-017-0351-y
3. World Health Organization. Enfermedades Cardiovasculares: Datos y cifras. 2017 [acceso 05/02/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
4. Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017; 3(1):7-11. DOI: https://doi.org/10.1007/s11897-017-0351-y
5. Jaramillo C, Gómez E, Hernández E, Saldarriaga, C, Flórez N, Buitrago R. Consenso Colombiano para el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Bogotá: Sociedad Colombiana de Cardiología y Cirugía Cardiovascular; 2014.
6. Ministerio de Salud y Protección Social. Análisis de Situación de Salud (ASIS). Bogotá. Dirección de epidemiologia y demografía; 2017 [acceso 05/02/2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis-colombia-2018.pdf
7. Santos GC, Liljeroos M, Dwyer A, Jaques C, Girard J, Strömberg A, et al. Symptom perception in heart failure: a scoping review on definition, factors and instruments. Eur J Cardiovasc Nurs. 2020;19(2):100-17. DOI: https://doi.org/10.1177/1474515119892797
8 Wilcox JE, Fang JC, Margulies KB, Mann, DL. Heart failure with recovered left ventricular ejection fraction: JACC scientific expert panel. J Am Coll Cardiol. 2020;76 (6):719-34. DOI: https://doi.org/10.1016/j.jacc.2020.05.075
9. Nadruz W, West E, Santos M, Skali H, Groarke JD, Forman DE, et al. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. Circ Heart Fail. 2016;9(4):e002826. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.115.002826
10. Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200. DOI: https://doi.org/10.1093/eurheartj/ehw128
11. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;37:3627-39. DOI: https://doi.org/10.1093/eurheartj/ehad195
12. Heidenreich PA, Bozkurt B, Aguilar, Allen LA, Byun, JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC journals. 2022;79(17):e263-e421. DOI: https://doi.org/10.1161/CIR.0000000000001063
13. Lakhani I, Leung KS, Tse G, Lee PW. Novel Mechanisms in Heart Failure with Preserved, Midrange, and Reduced Ejection Fraction. Front Physiol. 2019;10:874. DOI: https://doi.org/10.3389/fphys.2019.00874
14. Sato T, Yoshihisa A, Kanno Y, Suzuki S, Yamaki, T, Sugimoto K, et al. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol. 2017;24(18):1979-87. DOI: https://doi.org/10.1177/2047487317739079
15. Hsu JJ, Ziaeian B, Fonarow GC. Heart Failure with Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. JACC Heart Fail. 2017;5(11):763-71. DOI: https://doi.org/10.1016/j.jchf.2017.06.013
16. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. Boston: Little, Brown & Co.; 1994:253-56.
17. American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. Tenth Edition. Lippincott, Williams & Wilkins; 2017:569-74.
18. Sánchez-Ropero EM, Vera-Giraldoa CY, Navas-Ríos CM, Ortiz-Rangel SD, Rodríguez-Guevara C, Vargas-Montoya D, et al. Validation of a questionnaire for Measuring functional capacity in patients with heart failure in Colombia. Rev Colomb Cardiol. 2018;25(6):356-65. DOI: https://doi.org/10.1016/j.rccar.2018.04.004
19. Colet JC, Garin O, Rosés JL, Lorite NM, Leiro MG, Bueno MF, et al. Validación de la versión española del Kansas City Cardiomyopathy Questionnaire. Rev Esp Cardiol. 2011 [acceso 05/02/2021];64(1):51-8. Disponible en: https://www.revespcardiol.org/es-validacion-version-espanola-del-kansas-articulo-S0300893210000047
20. Garin O, Soriano N, Ribera A, Ferrer M, Pont À, Alonso J, et al. Validación de la versión en español del cuestionario Minnesota Living with Heart Failure Questionnaire. Rev Esp Cardiol. 2008 [acceso 05/02/2021];61(3):251-9. Disponible en: https://www.revespcardiol.org/es-validacion-version-espanola-del-minnesota-articulo-13116652
21. Kularatna S, Byrnes J, Chan YK, Carrington MJ, Stewart S, Scuffham PA, et al. Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions. Int J Cardiol. 2017;227:172-6. DOI: https://doi.org/10.1016/j.ijcard.2016.11.030
22. Lam CS, Voors AA, Piotr P, McMurray JJ, Solomon SD. Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. Eur Heart J. 2020;41(25):2353-5. DOI: https://doi.org/10.1093/eurheartj/ehaa158
23. Sauser K, Spertus JA, Pierchala L, Davis E, Pang PS. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire. J Card Fail. 2014;20(1):18-22. DOI: https://doi.org/10.1016/j.cardfail.2013.11.010
24. Cleland JG, Lyon AR, McDonagh T, McMurray JJ. The year in cardiology: heart failure. Eur Heart J. 2020;41(12):1232-48. DOI: https://doi.org/10.1093/eurheartj/ehz949
25. Kenny H, Dale A. Heart Failure in Type 2 Diabetes Mellitus: Impact of Glucose Lowering Agents, Heart Failure Therapies and Novel Therapeutic Strategies. Circ Res. 2019;124(1):121-41. DOI: https://doi.org/10.1161/CIRCRESAHA.118.311371
26. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2017;140(7):e294-e324. DOI: https://doi.org/10.1161/CIR.0000000000000691
27. Rodríguez-González MJ, Contreras J. De la insuficiencia cardíaca a la diabetes. ¿Existe un mecanismo común? Rev Col Cardiol. 2020;27:7-11. DOI: https://doi.org/10.1016/j.rccar.2019.12.007
28. Solomon SD. Vaduganathan M, Claggett BL, De Boer RA, DeMets D, Hernandez AF, et al. Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial. Heart Failure. 2022;10(3):184-97. DOI: https://doi.org/10.1016/j.jchf.2021.11.006
29. Ritsinger V, Nyström T, Saleh N, Lagerqvist B, Norhammar A. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry. Eur J Prev Cardiol. 2020;27:1890-901. DOI: https://doi.org/10.1177/2047487319901063
30. Oh GC, Cho H. Blood pressure and heart failure. Clin Hypertens. 2020;26:1-8. DOI: https://doi.org/10.1186/s40885-019-0132-x
31 Arnold SV, Silverman DN, Gosch K, Nassif ME, Infeld M, Litwin S, et al. Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction. JACC: Heart Failure. 2023;11:893-900. DOI: https://doi.org/10.1016/j.jchf.2023.03.017
32. Gómez-Otero I, Ferrero-Gregori A, Román AV, Amigo, JS, Pascual-Figal DA, Jiménez JD, et al. La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardíaca. Rev Esp de Cardiol. 2017 [acceso 05/02/2021];70:338-46. Disponible en: https://www.revespcardiol.org/es-la-fraccion-eyeccion-intermedia-no-articulo-S0300893216304134
33 Keteyian SJ, Michaels A. Heart failure in cardiac rehabilitation: a review and practical considerations. Journal of Cardiopulmonary Rehabilitation and Prevention. 2022;42(5):296-303. DOI: https://doi.org/10.1097/HCR.0000000000000713
34 Baccanelli G, Tomaselli M, Ferri U, Giglio A, Munforti C, Parati G, et al. Effects of cardiac rehabilitation on cardiopulmonary test parameters in heart failure: A real world experience. International Journal of Cardiology Cardiovascular Risk and Prevention. 2023;17:200178. DOI: https://doi.org/10.1016/j.ijcrp.2023.200178
35. Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, et al. Characterization of heart failure patients with mid‐range left ventricular ejection fraction-a report from the CHART‐2 Study. Eur J Heart Fail. 2017;19(10):1258-69. DOI: https://doi.org/10.1002/ejhf.807
36. Reddy YN, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, et al. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Eur J Heart Fail. 2020;22(6):1009-18. DOI: https://doi.org/10.1002/ejhf.1788
37. Ohori K, Yano T, Katano S, Kouzu H, Honma S, Shimomura K, et al. High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox. BMC geriatrics. 2021;21:1-11. DOI: https://doi.org/10.1186/s12877-020-01950-9
38. Garay A, Tapia J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, et al. Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study. J Clin Med. 2020;9(9):e2825. DOI: https://doi.org/10.3390/jcm9092825
39. Chen X, Xin Y, Hu W, Zhao Y, Zhang Z, Zhou Y. Quality of life and outcomes in heart failure patients with ejection fractions in different ranges. PLoS One. 2019;14(6):e0218983. DOI: https://doi.org/10.1371/journal.pone.0218983
40. Kallistratos M, Konstantinidis D, Dimitriadis K, Sanidas E, Katsi V, Androulakis E, et al. Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Arterial Hypertension of the Hellenic Society of Cardiology. Hellenic J Cardio. 2024;75:82-92. DOI: https://doi.org/10.1016/j.hjc.2023.08.008
41. Yin JS, Lin W, Yeo TJ. The Role of Exercise-based Cardiac Rehabilitation in Heart Failure. Current Pharmaceutical Design. 2023;29(7):494-501. DOI: 0.2174/1381612829666230217145100
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 David Alejandro Escobar-Vidal, Carlos Duvan Paez Mora, Juan Carlos Ávila-Valencia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Attribution-NonCommercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista. o admite fines comerciales. Permite copiar, distribuir e incluir el artículo en un trabajo colectivo (por ejemplo, una antología), siempre y cuando no exista una finalidad comercial, no se altere ni modifique el artículo y se cite apropiadamente el trabajo original. El Comité Editorial se reserva el derecho de introducir modificaciones de estilo y/o acotar los textos que lo precisen, comprometiéndose a respectar el contenido original.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
